REVB News and Press, Revelation Biosciences Inc. From 02/01/24

A look at the top 10 most actives in the United States PROSHARES TRUST (SQQQ) fell 3.3% to $12.36 on volume of 132,876,575 shares New York Community Bancorp Inc. (NYCB) fell 8.1% to $5.945 on volume of 103,690,183 shares Plug Power Inc. (PLUG) rose 2.4% to $4.555 on volume of 100,620,245 ...

2024-02-01 12:36:09 ET More on Mid-day movers & stocks. Nextracker Inc. 2024 Q3 - Results - Earnings Call Presentation Nextracker Inc. (NXT) Q3 2024 Earnings Call Transcript Nextracker Inc.: Riding The Solar Power Tide While Growing Profitably Nextracker ...

2024-02-01 10:00:10 ET More on Health Care Select Sector SPDR Healthcare In 2024: Navigating The Biopharma Bull Run XLV Likely Back To Outperforming XLV: Considering The Low-Maintenance Option To Navigate The Healthcare Sector Investors were most bullish on H...

2024-02-01 08:29:22 ET More on pre-market losers & stocks. Bullfrog AI stock rallies 32% on early brain research results Infobird announces new business deal in software development of information technology system Financial information for Bullfrog AI Holdings, ...

2024-02-01 07:04:13 ET More on Revelation Biosciences Seeking Alpha’s Quant Rating on Revelation Biosciences Historical earnings data for Revelation Biosciences Financial information for Revelation Biosciences Read the full article on Seeking Alpha ...

Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a life sciences company that is focused on harnessing the power of trained immunity for the prevention and treatment of disease, today announced the pricing of a public offering of 1,365,000 sh...

2024-01-31 10:00:03 ET More on Health Care Select Sector SPDR Healthcare In 2024: Navigating The Biopharma Bull Run XLV Likely Back To Outperforming XLV: Considering The Low-Maintenance Option To Navigate The Healthcare Sector Investors were most bullish on H...

2024-01-31 08:24:06 ET Guardion Health Sciences  ( GHSI ) +84% Announces Entry into Definitive Agreement to Sell its Well-Known Viactiv Brand and Business to Doctor’s Best Inc Ensysce Biosciences  ( ENSC ) +33% Announces Positive End of Phase 2 M...

2024-01-30 11:50:46 ET Gainers: Neximmune ( NEXI ) +163% . Pixelworks ( PXLW ) +47% . PepGen ( PEPG ) +37% . Rail Vision Ltd ( RVSN ) +36% . Bit Origin Ltd ( BTOG ) +34% . Vivos Therapeutics ( VVOS ) +32% . GRI Bi...

- Abstract Includes Positive Data from a Recently Completed Preclinical Ischemia Reperfusion Acute Kidney Injury Model - Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), announced today that new preclinical data on the p...